(Q36861789)

English

Hormone-refractory prostate cancer: what have we learned?

scientific article published on July 2007

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

title

Hormone-refractory prostate cancer: what have we learned? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16 August 2017

Manfred P Wirth

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

publication date

1 July 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

volume

100 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

page(s)

56-59

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

cites work

Survival of patients with hormone refractory prostate cancer in the prostate specific antigen era.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06957.X

retrieved

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06957.X

retrieved

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06957.X

retrieved

21 January 2018

Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06957.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1464-410X.2007.06957.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

PubMed publication ID

17594362

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17594362

retrieved

16 August 2017

(Q36861789)

Hormone-refractory prostate cancer: what have we learned?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)